First-line treatment of ovarian/tubal/peritoneal cancer FIGO stage IIB–IV with paclitaxel/carboplatin with or without epirubicin (TEC vs TC). A gynecologic cancer intergroup study of the NSGO, EORTC GCG, and NCIC CTG. Results on progression-free survival
Titel:
First-line treatment of ovarian/tubal/peritoneal cancer FIGO stage IIB–IV with paclitaxel/carboplatin with or without epirubicin (TEC vs TC). A gynecologic cancer intergroup study of the NSGO, EORTC GCG, and NCIC CTG. Results on progression-free survival
Auteur:
Kristensen, G.B. Vergote, I. Stuart, G. Del Campo, J.M. Kærn, J. Baekelandt, M. Lopez, A.B. Hirte, H. Aavall-Lundqvist, E. Lorenz, E. Cerar, O.